Sort   by:  
 Page size 
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
UnknownLipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Not available
S-EPMC8822604 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownRemdesivir for the Treatment of Covid-19 - Final Report.
Not available
S-EPMC7262788 | biostudies-literature
UnknownGenome-wide analysis identifies 12 loci influencing human reproductive behavior.
Not available
S-EPMC5695684 | biostudies-literature
UnknownEfficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
Not available
S-EPMC8523116 | biostudies-literature
UnknownEarly trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Not available
S-EPMC11181148 | biostudies-literature
UnknownAssociation Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
Not available
S-EPMC8261689 | biostudies-literature
UnknownNew loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk.
Not available
S-EPMC4740398 | biostudies-literature
UnknownIdentification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders.
Not available
S-EPMC3696959 | biostudies-literature
Sort   by:  
 Page size